These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Paraneoplastic syndromes of the neuromuscular junction: therapeutic options in myasthenia gravis, lambert-eaton myasthenic syndrome, and neuromyotonia. van Sonderen A; Wirtz PW; Verschuuren JJ; Titulaer MJ Curr Treat Options Neurol; 2013 Apr; 15(2):224-39. PubMed ID: 23263888 [TBL] [Abstract][Full Text] [Related]
6. Update on the evaluation and therapy of autoimmune neuromuscular junction disorders. Katz J; Barohn RJ Phys Med Rehabil Clin N Am; 2001 May; 12(2):381-97. PubMed ID: 11345014 [TBL] [Abstract][Full Text] [Related]
7. Autoimmune disorders of the neuromuscular junction. Lang B; Vincent A Curr Opin Pharmacol; 2009 Jun; 9(3):336-40. PubMed ID: 19428298 [TBL] [Abstract][Full Text] [Related]
13. Current therapy for Lambert-Eaton myasthenic syndrome: development of 3,4-diaminopyridine phosphate salt as first-line symptomatic treatment. Quartel A; Turbeville S; Lounsbury D Curr Med Res Opin; 2010 Jun; 26(6):1363-75. PubMed ID: 20377318 [TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to ion channels at the neuromuscular junction. Lang B; Vincent A Autoimmun Rev; 2003 Mar; 2(2):94-100. PubMed ID: 12848965 [TBL] [Abstract][Full Text] [Related]
15. Update in the Management of Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome. Bodkin C; Pascuzzi RM Neurol Clin; 2021 Feb; 39(1):133-146. PubMed ID: 33223079 [TBL] [Abstract][Full Text] [Related]
16. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status. Illa I J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667 [TBL] [Abstract][Full Text] [Related]
17. [The pathophysiology and treatment of autoimmune neuromuscular junction diseases]. Motomura M Rinsho Shinkeigaku; 2011 Nov; 51(11):872-6. PubMed ID: 22277398 [TBL] [Abstract][Full Text] [Related]
18. Immunoadsorption in patients with autoimmune ion channel disorders of the peripheral nervous system. Antozzi C Atheroscler Suppl; 2013 Jan; 14(1):219-22. PubMed ID: 23357168 [TBL] [Abstract][Full Text] [Related]
19. The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome. Maddison P; McConville J; Farrugia ME; Davies N; Rose M; Norwood F; Jungbluth H; Robb S; Hilton-Jones D J Neurol Neurosurg Psychiatry; 2011 Jun; 82(6):671-3. PubMed ID: 20392977 [TBL] [Abstract][Full Text] [Related]